being and becoming in the world
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”
It is now more than 3 years since I heard the above presentation at this Continuing Medical Education (CME) event: Dr Christmas considered the over- and under- prescribing of antidepressants … Continue reading “It’s an outrage!”
This is my BMJ Rapid Response, of the 6th January 2018 to Mike Thompson, CEO of the ABPI. [Association of the British Pharmaceutical Industry] I share Mike Thompson’s disappointment in some aspects … Continue reading Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients
This BMJ Editorial of the 30th June 2017 has had a number of responses: The Editorial was a consideration of Academy of Medical Sciences report ‘Enhancing the use of scientific evidence … Continue reading Unrealistic Medicine
This letter, by me, was published in the BMJ on the 7 April 2014: This is a BMJ rapid-response reply by Assistant Professor Shailendra Mohan Tripathi Ambrish Kumar, Department of … Continue reading “Anti-dementia” drugs
The featured image (above) is from the Alzheimer’s Society and is now their position statement on current anti-dementia medications. More than three months have now passed since the G8 dementia summit … Continue reading Only now